- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01769742
Early Mobility Bundle to Prevent Hospital Acquired Pneumonia (HAP) in Medical Inpatients
Use of Early Mobilisation to Reduce Incidence of Hospital Acquired Pneumonia in Medical Inpatients
Hospital acquired pneumonia (HAP) is a common complication of extended hospital stay. In surgical specialities and critical care early physiotherapy is a recognised way of preventing such infections, and reducing length of hospital stay (LOS), however prevention of this problem is less well studied in medical inpatients.
The investigators propose a pilot study to assess the impact of introducing an early mobilisation strategy to general medical and respiratory wards at an acute Trust in the United Kingdom (UK). The investigators will recruit all new admissions to each of 2 respiratory and 2 elderly care wards - 1 of each ward type will be allocated to receive extra physiotherapy input targeting new admissions for early mobilisation. Patients' usual mobility, current mobility and actual activity levels will be studied by accelerometer and simple patient questionnaire in the first 48 hours of admission, and compared between groups. Incidence of HAP and total LOS will be recorded and compared between groups.
The investigators hypotheses are that the physiotherapy intervention will increase activity levels, reduce incidence of HAP and reduce LOS. The latter may result in cost savings to the National Health Service (NHS), which the investigators will model using local tariff data.
The investigators plan to use our data to power a larger randomised controlled study, or if the intervention is a marked success, such that a control group would be unethical, then a wider service development and evaluation programme.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
West Midlands
-
Birmingham, West Midlands, Regno Unito, B9 5SS
- Heart of England NHS Trust
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Any medical inpatient
Exclusion Criteria:
- Nil for main study
- Immobile patients and those unable to consent will be excluded from the sub-study using activity reporting and monitoring by Actigraph
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Early mobility bundle
Delivery of early targeted physiotherapy to patients on the interventional wards; to comprise assessment and communication of mobility to ward staff and patient, provision of mobility aids, guidance and encouragement to patient and staff to allow patient to dress and mobilise independently if clinically safe to do so
|
|
Nessun intervento: Usual care
Usual physiotherapy service only
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Incidence of hospital acquired pneumonia
Lasso di tempo: Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured, and expressed as incidence/week of stay.
Patients whose length of stay is lower or higher than average will not be excluded.
|
Duration of hospital stay (up to 12 days)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Length of hospital stay in days
Lasso di tempo: Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured.
Patients whose length of stay is lower or higher than average will not be excluded
|
Duration of hospital stay (up to 12 days)
|
Incidence of falls
Lasso di tempo: Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured.
Patients whose length of stay is lower or higher than average will not be excluded
|
Duration of hospital stay (up to 12 days)
|
Incidence of pressure area problems
Lasso di tempo: Duration of hospital stay (up to 12 days)
|
The average length of stay is 8 days on the respiratory ward and 12 days on elderly care.
This is the time period in which incidence of hospital acquired pneumonia will be measured.
Patients whose length of stay is lower or higher than average will not be excluded
|
Duration of hospital stay (up to 12 days)
|
Altre misure di risultato
Misura del risultato |
Lasso di tempo |
---|---|
Activity levels as reported by patient
Lasso di tempo: Days 1 and 2 of admission to ward
|
Days 1 and 2 of admission to ward
|
Activity levels as measured by Actigraph
Lasso di tempo: Day 1 and 2 of admission to ward
|
Day 1 and 2 of admission to ward
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Alice Turner, University of Birmingham
Pubblicazioni e link utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- RG-12-237
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Polmonite acquisita in ospedale
-
Weill Medical College of Cornell UniversityCompletatoPazienti medici moderatamente malati presso il Cornell Campus del New York-Presbyterian HospitalStati Uniti
Prove cliniche su Early mobility bundle
-
Zimmer BiometAttivo, non reclutanteRisultati clinici | Sopravvivenza | Sicurezza | Risultati funzionali | Risultati radiologiciStati Uniti
-
Stryker Trauma GmbHCompletatoNecrosi della testa del femore | Osteoartrosi primaria | Lussazioni congenite | Frattura del collo del femore | Osteoartrosi post-traumatica dell'anca n
-
Zimmer BiometIscrizione su invitoMalattie articolari | Artrite reumatoide | Necrosi avascolare | Fratture del collo del femore | Artrosi dell'anca | Lussazione, Anca | Fratture trocanteriche | Interventi di revisioneBelgio, Stati Uniti, Corea, Repubblica di, Italia
-
Medacta International SAAttivo, non reclutante
-
Kean UniversityCompletato
-
Kepler University HospitalReclutamento
-
Rockfield Medical DevicesHorizon 2020 - European CommissionIscrizione su invitoAlimentazione enteraleStati Uniti
-
Chung Shan Medical UniversityCompletato
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; London Health Sciences Centre; Mindfulness...CompletatoDisturbi psicotici | SchizofreniaCanada
-
National University of SingaporeCompletatoSviluppo del bambinoSingapore